-
1301
Prevalence of GCKR rs1260326 Variant in Subjects with Obesity Associated NAFLD and T2DM: A Case-Control Study in South Punjab, Pakistan
Published 2023-01-01“…The glucokinase regulatory protein (GCKR) regulates glycogen metabolism and insulin secretion, and the GCKR rs1260326 is a putative single nucleotide polymorphism (SNP) associated with metabolic disorders including nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM). …”
Get full text
Article -
1302
-
1303
Economic Evaluation of Boceprevir for the Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Hungary
Published 2013-06-01“…The lifetime incidence of severe liver disease events (DC, HCC, LT, LD) were projected to decrease by 45% and 61% in treatment-naïve and treatment-experienced patients treated with triple therapy groups in comparison with PEG-RBV treatment. …”
Get full text
Article -
1304
-
1305
-
1306
Drains vs. no drains following burr-hole evacuation of chronic subdural hematoma
Published 2024-12-01“…Exclusion Criteria: Bilateral chronic subdural haemorrhage on CT scan, recurrent CSDH, patients with shunt in-situ, patients with bleeding-related conditions (INR > 2.5, BT > 7 min, count of platelets < 60000) or on anticoagulant drugs, patients with severe systemic ailment such as renal failure (Serum Creatinine > 2.5), chronic liver disease (ultrasound shows liver cirrhosis and splenomegaly) and known ischemic heart disease were excluded from this study Materials and Methods: In this study, 100 participants were randomly assigned to two equal groups. …”
Get full text
Article -
1307
Autoimmune Hepatitis with Acute Presentation: Clinical, Biochemical, and Histological Features of 126 Patients
Published 2022-01-01“…Autoimmune hepatitis (AIH) is a chronic liver disease with a relevant inflammatory component and an unknown etiology. …”
Get full text
Article -
1308
Relationship of Circulating Fetuin-A Levels with Body Size and Metabolic Phenotypes
Published 2018-01-01“…Although nonalcoholic fatty liver disease (NAFLD) is strongly associated with obesity and metabolic syndrome, the relationship between these phenotypes and fetuin-A, a representative hepatokine, has not been explored. …”
Get full text
Article -
1309
Acute-on-Chronic Liver Failure in Pregnant Patients with Chronic Hepatitis B: A Retrospective Observational Case Series Study
Published 2020-01-01“…Acute-on-chronic liver failure (ACLF) is common in patients with end-stage liver disease and chronic hepatitis B (CHB) or hepatitis B virus- (HBV-) related cirrhosis. …”
Get full text
Article -
1310
Glycyrrhizin attenuates renal inflammation in a mouse Con A-hepatitis model via the IL-25/M2 axis
Published 2024-12-01“…Hepatorenal syndrome (HRS) is a functional acute renal impairment that occurs in severe liver disease, and we found that kidney injury also occurs in Con A-induced experimental hepatitis in mice. …”
Get full text
Article -
1311
Ketosis Onset Type 2 Diabetes Had Better Islet β-Cell Function and More Serious Insulin Resistance
Published 2014-01-01“…Our results showed that ketosis onset group had higher prevalence of nonalcoholic fatty liver disease (NAFLD) than nonketotic group (P=0.04). …”
Get full text
Article -
1312
Immediate management of a cirrhosis-induced severe pericardial effusion: a case report and review of the literature
Published 2025-01-01“…Autoimmune hepatitis is a chronic inflammatory liver disease characterized by interface hepatitis, elevated transaminase levels, autoantibodies, and increased immunoglobulin G levels. …”
Get full text
Article -
1313
Validity of serum autotaxin and Doppler ultrasound as noninvasive markers of esophageal varices in patients with liver cirrhosis
Published 2025-01-01“…Child–Pugh classification, fibrosis-4 (FIB-4), age to platelet index (API), model for end-stage liver disease (MELD), platelet/splenic diameter, portal vein velocity, flow volume, and serum autotaxin were entered in stepwise logistic regression model for prediction of esophageal varices, and serum autotaxin, portal vein velocity, and flow volume were significant in multivariate regression analysis with sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 96.25%, 75%, 93.9%, and 83.33%, respectively. …”
Get full text
Article -
1314
Risk Factors of Multidrug-Resistant Bacteria in Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis
Published 2020-01-01“…The meta-analysis results suggested that prior antibiotic treatment, inappropriate antibiotic therapy, chronic lung disease, chronic liver disease and cerebral disease, prior MDR and PA infection/colonization, recent hospitalization, longer hospitalization stay, endotracheal tracheostomy and mechanical ventilation, tube feeding, nursing home residence, and higher disease severity score were independent risk factors for MDR bacteria. …”
Get full text
Article -
1315
Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice
Published 2018-01-01“…Nonalcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance. …”
Get full text
Article -
1316
Comparison of glimepiride and linagliptin in the treatment of non-alcoholic hepatic disease with type 2 diabetes mellitus
Published 2023-02-01“…Introduction Nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes mellitus (T2DM) is associated with severe clinical outcomes. …”
Get full text
Article -
1317
Rifaximin treatment in patients with severe alcoholic hepatitis: A multicenter, randomized controlled, open-label, pilot trial
Published 2025-01-01“…The mean Model for End-stage Liver Disease (MELD) scores were 24.4 and 27.5 in the control and rifaximin groups, respectively (P = 0.106). …”
Get full text
Article -
1318
Comparison of Resistive Index, Pulsatility Index, and Arterial Waveform at the Comparison of Resistive Index, Pulsatility Index, and Arterial Waveform at the Site of Hepatic Artery...
Published 2025-01-01“…Background: Nonalcoholic fatty liver disease (NAFLD) is common. Noninvasive methods to assess fibrosis stage are limited, and biopsy remains the gold standard. …”
Get full text
Article -
1319
Alpha Mangostin Inhibits the Proliferation and Activation of Acetaldehyde Induced Hepatic Stellate Cells through TGF-β and ERK 1/2 Pathways
Published 2018-01-01“…Alcohol-induced fibrosis may develop into cirrhosis, one of the major causes of liver disease mortality. Previous studies have shown that alpha mangostin can decrease ratio of pSmad/Smad and pAkt/Akt in TGF-β-induced liver fibrosis model in vitro. …”
Get full text
Article -
1320
Glycyrrhizinate Monoammonium Cysteine-Loaded Lipid Nanoparticles Allow for Improved Acute Liver Injury Therapy
Published 2025-01-01“…This study contributes valuable insights into the utilization of LNPs in liver disease treatment, presenting a promising direction for future clinical applications.…”
Get full text
Article